- About
- Medical Weight Loss
- Botox
- Hormone Optimization
- Peptide Therapy
- Sexual Health
- Health Testing
We will be closed Monday Jan 18th for the MLK holiday.
Telemedicine Appointments Available.
We will be closed Monday Jan 18th for the MLK holiday.
Telemedicine Appointments Available.
This product is currently unavailable
Cerebrolysin is a synthetic nootropic drug which consists of low-molecular peptides and possesses neuroprotective and neurotrophic repair properties. The active fragment of cerebrolysin is made of proteins with very low molecular masses that do not exceed 10.000 daltons. This means they can penetrate the blood-brain barrier and reach neurons directly. Cerebrolysin has been proven to have neurotrophic action similar to nerve growth factors, which cause peripheral and central neuronal stimulation. It improves efficiency within the brain’s aerobic metabolic processes and improves intracellular peptide synthesis. The neuroprotective properties of this nootropic agent help to shield neurons from lactocidosis to prevent formation of free radicals. It has been used for treating stroke, traumatic brain injury, dementia, and Alzheimer’s disease.
Benefits of Cerebrolysin:
Cerebrolysin is safe and generally well-tolerated by patients, side effects are usually mild and temporary and may include:
Conclusion:
A few small clinical trials have reported that cerebrolysin can improve cognitive function in older people with memory problems and in those with schizophrenia, although the effects are modest. In a trial with schizophrenia patients, cerebrolysin treatment improved cognition and memory. Another trial of older adults with memory loss found that a peptide preparation derived from cerebrolysin improved memory performance but not verbal fluency. The effect on memory was lower than that of currently approved drugs for Alzheimer's disease. An uncontrolled clinical trial reported that healthy elderly people had better memory performance after one dose of cerebrolysin but this result could have been caused by the placebo effect.
No clinical studies have tested whether cerebrolysin can prevent dementia, but some preclinical research supports the idea. In preclinical studies, cerebrolysin protected neurons and brain slices from damage, reduced inflammation, promoted the formation of new neural connections (synapses), lessened cognitive impairment and reduced the plaques and tangles common in Alzheimer’s patients.
Research:
Cerebrolysin in Alzheimer’s disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent (M. Panisset, S. Gauthier, H. Moessler, M. Windisch)
Conclusions: Cerebrolysin treatment was well tolerated and resulted in significant improvements in the global score two months after the end of active treatment.
Transformyou:
4025 S. McClintock Dr #210
Tempe, AZ 85282
Office: 480.839.4131
Get Directions
Office Hours:
Monday and Wednesday: 9 - 6 PM
(Closed for lunch 12:-1:30)
Tuesday: 9 - 3 PM
Friday: 9 - 4 PM
powered by Tribute Media, an inbound web marketing agency.